R. Rupprecht et al., NEUROACTIVE STEROID CONCENTRATIONS FOLLOWING METYRAPONE ADMINISTRATION IN DEPRESSED-PATIENTS AND HEALTHY-VOLUNTEERS, Biological psychiatry, 44(9), 1998, pp. 912-914
Background: There is evidence that treatment with the 11 beta-hydroxyl
ase inhibitor metyrapone may represent an alternative treatment strate
gy in major depression, As a consequence of inhibition of cortisol syn
thesis the overdrive of corticotropin leads to an accumulation of prec
ursor steroids. However, the effects of metyrapone on the concentratio
ns of endogenous neuroactive steroids that modulate ion channels, e.g.
, the GABA(A) receptor, have not vet been studied systematically. Meth
ods: Therefore, we quantified the concentrations of an array of neuroa
ctive steroids following administration of 1.5g metyrapone before and
after pretreatment with I mg dexamethasone in 19 patients suffering fr
om severe depression in comparison to 13 healthy controls by means of
a highly sensitive gas chromatography/mass spectrometry analysis. Resu
lts: The administration of metyrapone induced a pronouced increase in
all neuroactive steroids studied both in patients and controls that wa
s prevented by dexamethasone pretreatment. Conclusions: Thus, the psyc
hotropic properties of endogenous neuroactive steroids may contribute
to the antidepressant propel-ties of metyrapone in the treatment of ma
jor depression, (C) 1998 Society of Biological Psychiatry.